According to Health Yuan's annual performance forecast for 2021, the company expects the net profit attributed to shareholders of listed companies to be 1.255 billion yuan to 1.367 billion yuan in 2021, an increase of 134 million yuan to 246 million yuan compared with 2020, an increase of 12% to 22% over the same period last year. It is estimated that the non-net profit attributable to shareholders of listed companies is 1.141 billion yuan to 1.237 billion yuan, an increase of 174 million yuan to 271 million yuan compared with 2020, an increase of 18% to 28% over the same period last year.
The chairman of the company is Zhu Baoguo. Mr. Zhu Baoguo: born in 1962, with a bachelor's degree, he was the director of Henan Xinxiang Waterborne Resin Research Institute, vice chairman and general manager of Henan Feilong Fine Chemical products Co., Ltd., and has been the general manager and vice chairman of the company since 1992. He is currently the chairman of the company and the chairman of Lizhu Pharmaceutical Group Co., Ltd.
This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If you have any questions, please contact us.